Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

307 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PSMA-D4 Radioligand for Targeted Therapy of Prostate Cancer: Synthesis, Characteristics and Preliminary Assessment of Biological Properties.
Garnuszek P, Karczmarczyk U, Maurin M, Sikora A, Zaborniak J, Pijarowska-Kruszyna J, Jaroń A, Wyczółkowska M, Wojdowska W, Pawlak D, Lipiński PFJ, Mikołajczak R. Garnuszek P, et al. Among authors: pawlak d. Int J Mol Sci. 2021 Mar 8;22(5):2731. doi: 10.3390/ijms22052731. Int J Mol Sci. 2021. PMID: 33800517 Free PMC article.
New forms of radionuclide therapy with (90)Y in oncology.
Hubalewska-Dydejczyk A, Jurczak W, Sowa-Staszczak A, Kunikowska J, Królicki L, Gilis-Januszewska A, Giza A, Szurkowska M, Pach D, Głowa B, Mikołajczak R, Pawlak D, Stefańska A, Huszno B, Skotnicki AB. Hubalewska-Dydejczyk A, et al. Among authors: pawlak d. Nucl Med Rev Cent East Eur. 2008;11(1):5-11. Nucl Med Rev Cent East Eur. 2008. PMID: 19173181 Clinical Trial.
Efficacy of radionuclide treatment DOTATATE Y-90 in patients with progressive metastatic gastroenteropancreatic neuroendocrine carcinomas (GEP-NETs): a phase II study.
Cwikla JB, Sankowski A, Seklecka N, Buscombe JR, Nasierowska-Guttmejer A, Jeziorski KG, Mikolajczak R, Pawlak D, Stepien K, Walecki J. Cwikla JB, et al. Among authors: pawlak d. Ann Oncol. 2010 Apr;21(4):787-794. doi: 10.1093/annonc/mdp372. Epub 2009 Oct 15. Ann Oncol. 2010. PMID: 19833821 Free article. Clinical Trial.
Clinical results of radionuclide therapy of neuroendocrine tumours with 90Y-DOTATATE and tandem 90Y/177Lu-DOTATATE: which is a better therapy option?
Kunikowska J, Królicki L, Hubalewska-Dydejczyk A, Mikołajczak R, Sowa-Staszczak A, Pawlak D. Kunikowska J, et al. Among authors: pawlak d. Eur J Nucl Med Mol Imaging. 2011 Oct;38(10):1788-97. doi: 10.1007/s00259-011-1833-x. Epub 2011 May 7. Eur J Nucl Med Mol Imaging. 2011. PMID: 21553086 Free PMC article. Clinical Trial.
Peptide receptor radionuclide therapy as a potential tool for neoadjuvant therapy in patients with inoperable neuroendocrine tumours (NETs).
Sowa-Staszczak A, Pach D, Chrzan R, Trofimiuk M, Stefańska A, Tomaszuk M, Kołodziej M, Mikołajczak R, Pawlak D, Hubalewska-Dydejczyk A. Sowa-Staszczak A, et al. Among authors: pawlak d. Eur J Nucl Med Mol Imaging. 2011 Sep;38(9):1669-74. doi: 10.1007/s00259-011-1835-8. Epub 2011 May 11. Eur J Nucl Med Mol Imaging. 2011. PMID: 21559978 Free PMC article. Clinical Trial.
307 results